Rothschild & Co Asset Management US’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $6.82M | Buy |
|
|||||
|
2022
Q3 | $5.8M | Sell |
|
|||||
|
2022
Q2 | $2.99M | Sell |
|
|||||
|
2022
Q1 | $4.34M | Sell |
|
|||||
|
2021
Q4 | $4.72M | Sell |
|
|||||
|
2021
Q3 | $8.48M | Sell |
|
|||||
|
2021
Q2 | $10.2M | Sell |
|
|||||
|
2021
Q1 | $10.7M | Sell |
|
|||||
|
2020
Q4 | $12.2M | Sell |
|
|||||
|
2020
Q3 | $11M | Sell |
|
|||||
|
2020
Q2 | $11.8M | Buy |
|
|||||
|
2020
Q1 | $7.11M | Sell |
|
|||||
|
2019
Q4 | $9.09M | Buy |
|
|||||
|
2019
Q3 | $456K | Buy |
|
|||||
|
2019
Q2 | $356K | Sell |
|
|||||
|
2019
Q1 | $437K | Sell |
|
|||||
|
2018
Q4 | $995K | Buy |
|
|||||
|
2018
Q3 | $1.21M | Buy |
|
|||||
|
2018
Q2 | $1.14M | Sell |
|
|||||
|
2018
Q1 | $1.37M | Sell |
|
|||||
|
2017
Q4 | $1.76M | Sell |
|
|||||
|
2017
Q3 | $1.46M | Sell |
|
|||||
|
2017
Q2 | $1.43M | Sell |
|
|||||
|
2017
Q1 | $1.18M | Sell |
|
|||||
|
2016
Q4 | $1.26M | Buy |
|
|||||
|
2016
Q3 | $175K | Buy |
|
|||||
|
2016
Q2 | $143K | Buy |
|